N
IMNM icon

Nuveen’s Immunome IMNM Stock Holding History

Nuveen’s Portfolio IMNM Stock Details IMNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6.68M Buy
305,254
+135,908
+80% +$3.02M ﹤0.01% 1766
2025
Q4 		$3.64M Buy
169,346
+24,002
+17% +$421K ﹤0.01% 2050
2025
Q3 		$1.7M Sell
145,344
-96,066
-40% -$956K ﹤0.01% 2363
2025
Q2 		$2.25M Buy
241,410
+1,470
+0.6% +$12.1K ﹤0.01% 2252
2025
Q1 		$1.61M Buy
239,940
+53,853
+29% +$517K ﹤0.01% 2426
2024
Q4 		$1.98M Sell
186,087
-2,931
-2% -$35.4K ﹤0.01% 2395
2024
Q3 		$2.76M Sell
189,018
-110,272
-37% -$1.57M ﹤0.01% 2266
2024
Q2 		$3.62M Buy
+299,290
New +$4.68M ﹤0.01% 2101

Other funds holding IMNM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $352M AUM 220.14% 1-Year Est. Return

Nuveen's IMNM Position: Q1 2026 in Review

Nuveen increased its Immunome (IMNM) stake by 80% in Q1 2026, buying an estimated $3.02M and bringing the position to 305,254 shares worth $6.68M. The position accounts for ﹤0.01% of the portfolio, ranked #1766.

Nuveen first reported a position in IMNM in Q2 2024 and has held it in 8 quarters since. 200 funds tracked by Wall St. Rank hold IMNM as of Q1 2026.

  • Nuveen held 305,254 shares of Immunome worth $6.68M as of Q1 2026.
  • Nuveen bought 135,908 Immunome shares in Q1 2026, an estimated $3.02M.
  • Immunome made up ﹤0.01% of Nuveen's portfolio in Q1 2026, its #1766 holding.
  • Nuveen first reported a position in Immunome in Q2 2024 and has held it in 8 quarters since.
  • 200 funds tracked by Wall St. Rank held Immunome as of Q1 2026.

Based on Nuveen's 13F filing for Q1 2026, filed 30 Apr 2026.